Navigation Links
Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
Date:9/24/2008

II studies of ANA598 during 2009; and (v) expectations regarding the evolution of the market for HCV therapies. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause Anadys' actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. For example, the results of preclinical and early clinical studies may not be predictive of future results, and Anadys cannot provide any assurances that ANA598 will not have unforeseen safety issues, will have favorable results in future clinical trials or will receive regulatory approval. In addition, Anadys' results may be affected by risks related to competition from other biotechnology and pharmaceutical companies, its effectiveness at managing its financial resources, its ability to successfully develop and market products, difficulties or delays in its preclinical studies or clinical trials, difficulties or delays in manufacturing its clinical trials materials, the scope and validity of patent protection for its products, regulatory developments involving future products and its ability to obtain additional funding to support its operations. Risk factors that may cause actual results to differ are more fully discussed in Anadys' SEC filings, including Anadys' Form 10-K for the year ended December 31, 2007 and Anadys' Form 10-Q for the quarter ended June 30, 2008. All forward-looking statements are qualified in their entirety by this cautionary statement. Anadys is providing this information as of this date and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.


'/>"/>
SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
2. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
3. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
4. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
5. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
6. Oramed Pharmaceuticals Commences Phase 2A Trials of its Oral Insulin Capsule on Type 1 Diabetics
7. Vion Pharmaceuticals Enters into Agreement to Conduct a Phase I/II Clinical Trial of Cloretazine(R) in Combination with Induction Therapy in Poor Prognosis AML Patients
8. Memory Pharmaceuticals and Roche Expand R3487/MEM 3454 Development Program
9. Oramed Pharmaceuticals Launches GLP1-Analog Program, Based on its Proprietary Drug Delivery Platform
10. Cadence Pharmaceuticals Updates Omigard(TM) Clinical Timeline
11. VIA Pharmaceuticals to Present at American Heart Association Scientific Sessions 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... MILFORD, Mass. , Feb. 26, 2015 /PRNewswire/ ... developing novel therapeutics for the treatment of virus ... , CPA, has been appointed Vice President of ... be responsible for financial and administrative activities, including ... He reports to Douglas J. Jensen , ...
(Date:2/26/2015)... February 26, 2015 Vectorious ... cardiac monitoring system for patients suffering from congestive ... closed a $5 million financing round. Investors in ... owned jointly by Yehuda Zisapel and Prof. ... Gilon, Gur Muntzer and others; and the U.S.-based ...
(Date:2/26/2015)... Colo. , Feb. 26, 2015 ... installation Company specializing in commercial indoor cannabis cultivation ... continued evolution from start-up to fast-paced manufacturing and ... Tom Bollich , current Director and CEO, will ... "I,m extremely proud of what the team has ...
Breaking Medicine Technology:Jonathan P. Freve, CPA, Joins Spring Bank Pharmaceuticals as Vice President of Finance 2Vectorious Medical Technologies Completes $5M Raise 2Surna, Inc. Announces Senior Leadership Changes 2Surna, Inc. Announces Senior Leadership Changes 3Surna, Inc. Announces Senior Leadership Changes 4
... today launched a new program to help county residents deal ... with the National Association of Counties (NACo), the free Prescription ... offers an average of 24 percent savings off the retail ... be used by those who do not have insurance or ...
... Perrigo Company (Nasdaq: PRGO ; TASE) today ... quarter fiscal 2012 on Thursday, October 27, 2011 at approximately ... at 10:00 a.m. (ET) hosted by Joseph C. Papa, Perrigo,s ... will be available live via webcast to interested parties on ...
Cached Medicine Technology:Yamhill County Introduces Prescription Discount Card to Help Alleviate High Costs 2
(Date:2/27/2015)... Philanthropy is a continuous force restoring people’s faith in ... restore that faith by helping the people in their community. ... team gives to the local children in need of help. ... have been added as the need arose. , Advocates ... counseling for women who have suffered physical and emotional abuse. ...
(Date:2/27/2015)... Seattle, WA (PRWEB) February 27, 2015 ... population health management organizations, has been named a ... Platinum Awards in recognition of outstanding commitment toward ... Qualis Health’s success in reducing hospital readmission rates ... program. , “We are honored to receive this ...
(Date:2/27/2015)... Jvion announced today that leading ... the Atlanta-based software company through a strategic partnership ... predictive capabilities suite within the provider market. Jvion ... prevents financial and clinical losses within hospitals. Capitalizing ... prevent patient deterioration and suffering, the support of ...
(Date:2/27/2015)... 2015 UAS LifeSciences, will showcase their ... Products Expo West, March 6 to 8 in Anaheim, ... release the hands down best tasting probiotic in the ... extra zing of Vitamin C. This is a companion ... NutrAward 2014, Delicious Living’s Supplement Award and Taste for ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Aligned ... five local neighborhood health centers, officially welcomes Dr. ... Medicine based in Aligned Modern Health’s Lincoln Square, ... graduated from the National University of Health Sciences ... Award. She has completed post-graduate coursework in ...
Breaking Medicine News(10 mins):Health News:Mr. And Mrs. Smits Proves That Altruism Works All Year Round 2Health News:Qualis Health Named Award Finalist for Care Transitions Work 2Health News:Jvion Gains Strategic Collaboration Partner in Martin Ventures 2Health News:Jvion Gains Strategic Collaboration Partner in Martin Ventures 3Health News:UAS LifeSciences to Launch UP4 Adult Cubes at Expo West 2Health News:Chicago Wellness Centers Welcomes New Lead Functional Medicine Doctor to Staff 2Health News:Chicago Wellness Centers Welcomes New Lead Functional Medicine Doctor to Staff 3
... , , , , PHILADELPHIA, Jan. 11 ... than $566,000 in a state-of-the-art inventory management system - ... stock accuracy and the Penn Customer Portal. This system ... its class in the U.S. or Europe to provide ...
... the eye makeup ,that gave Queen Nefertiti and other ancient ... the eye. Scientists in France are reporting that the alluring ... or treat eye disease by doubling as an infection-fighter. Their ... issue of the American Chemical Society (ACS) semi-monthly journal, ...
... N.C. Obese white men who have both diabetes ... prostatectomy than do men without diabetes who undergo the ... Center appearing in Cancer Epidemiology, Biomarkers & Prevention ... associated with a lower risk of developing prostate cancer ...
... vaccinated, researchers say , MONDAY, Jan. 11 (HealthDay News) ... patients who take the drug rituximab (Rituxan): The flu ... six months following treatment with Rituxan. , The researchers ... some protection against the flu, and the vaccine won,t ...
... ... Sunday, January 16-17, 2010, 9 a.m. to 5 p.m. The mattress retailer will be presenting ... ... & Fitness Expo on Saturday and Sunday, January 16-17, 2010, 9 a.m. to 5 p.m. ...
... , ... to adults with a chronic medical condition, and can be completed anonymously. It can ... encouraged. The survey will be closed on Feb. 7, 2010. , ... Melbourne, Fla. (Vocus) January 11, 2010 -- The ...
Cached Medicine News:Health News:Penn Pharma Invests In World-Class Inventory Management System 2Health News:Race, obesity affect outcomes among diabetics following prostatectomy 2Health News:Rheumatoid Arthritis Drug Lowers Flu Shot Effectiveness 2Health News:Mattress Warehouse to Present at the NBC-4 Health & Fitness Expo in Washington, DC 2Health News:National Fatigue Survey Examines Common Factors in Fatigue Across Chronic Medical Conditions 2Health News:National Fatigue Survey Examines Common Factors in Fatigue Across Chronic Medical Conditions 3
... MDS display system provides maximum impact for ... This unique approach to displaying frames allows ... and create appealing, flexible and eye-catching displays. ... and your patients are motivated. Removable holders. ...
A pre-assembled, hexagonal, revolving tower display with two round 19.75" in diameter adjustable shelves. Enjoy 3.5 square feet of elegant shelf space for your products....
A pre-assembled, rectangular shadow box/wall hanging display. It have 3 adjustable shelves with tempered glass, four 50 watt halogen top lights, laminated deck, dust resistant and electrical cord wit...
Classic is proud to provide top-quality vision eyewear to physicians, health maintenance organizations (HMOs), and numerous state and federal government programs. Classic Laboratory produces over 150...
Medicine Products: